Dr Reddys Laboratories informs about press release
Dr Reddys Laboratories has informed that it enclosed a Press Release ‘Dr. Reddy’s Laboratories announces launch of India’s first DCGI-approved Semaglutide injection ‘Obeda’ for Type 2 Diabetes’.
The above information is a part of company’s filings submitted to BSE.
